WOMENS-HEALTH Messages for January, 2003: Premarin & Ovarian Cancer

Premarin & Ovarian Cancer

From: anonymous@obgyn.net
Fri, 10 Jan 2003 14:56:08 -0500

Messages sorted by: [ date ][ thread ][ subject ][ author ]
Next message: Linda: "Re: Please read, Ascus Cells Associated with Disease?"
Previous message: Rebecca: "vaginal pain and bump"

In 1972, my wife had been diagnosed with ovarian cancer, when she presented with a left DVT (deep vein thrombosis) and pulmonary embolism at a hospital in San Diego, CA. DVT is not uncommon in patients with ovarian cancer (it may be a presenting sign). Workup which was triggered by this presentation revealed that she did have an ovarian carcinoma for which she was cured with total abdominal hysterectomy and Chlorambucil (Leukeren) treatment. This postoperative chemotherapy drug was among the slowest acting and least toxic of the alkylating agents (well tolerated oral drugs). By giving chemotherapy more often, at lower doses, it can prevent the regrowth of blood vessels that feed tumors. Depression of the immune system is slow and reversible, allowing it to regenerate and contribute to healing. A malfunctioning immune system can fail to stop the growth of cancer cells. When caught at this earliest stage, ovarian cancer has a good prognosis. At Stage I, ovarian cancer has a five-year survival rate of around 93%. She went twenty-four years before experiencing any recurrent ovarian cancer.

Why, after 24 years, had ovarian cancer cells proliferate inside her diaphragm? Her presentation of a left DVT and PE in 1972 (DVT is not uncommon in patients with ovarian cancer and it may be a presenting sign) enabled the doctors to find her ovarian cancer at it's earliest stage where just surgical oncology alone is over 93% curative. Her postoperative chemotherapy was among the slowest acting and least toxic of the alkylating agents whereas the depression of the immune system was slow and reversible, allowing it to regenerate and contribute to healing her cancer. Plus, she was only 40 years of age.

My wife had been taking Premarin for over twenty years. That's right! Premarin. This past summer, the National Institutes of Health had published articles about two large studies indicating the increased risk of ovarian cancer linked to Estrogen Replacement Therapy. For women who used estrogen for 20 years or more it was increased by more than 300% (3-fold) compared to women who had never taken it.

Gregory D. Pawelski

Ann's Story: http://pathology2.jhu.edu/ovca/story.cfm?PersonID=33

p.s.

Touted as the best-selling cancer drug in history began 40 years ago this past summer (2002). Taxol was found to be virtually insoluble in water. "It had the solubility of a brick". The compound wouldn't dissolve very much in any solution. Without a way to get it into a cancer patient, what good was it? It was discovered that something Taxol would dissolve in that "might" work in a reasonably "safe" intravenous solution in humans. It was an elixir made of castor oil and marketed as Cremophor EL. It was the "only" answer. However, this castor-oil carrier is suspected as the culprit behind the misery which includes nausea, vomiting, joint pain, appetite loss, brittle hair and tingling sensations in hands and feet (neuropathy). The much ballyhooed drug was no panacea.

And the picture wasn't all that rosy as a cancer-fighter. Numerous cancer patients had the drug bounce off their tumors, doing little if any good. Of course, no one knew if it was hundreds, thousands, tens of thousands or millions of patients. A lot of cancer patients who succumb, get the wrong information on their death certificates. Death by "side effects of cancer treatment" is not the same as "complications of cancer". Cancer patients die with incorrect, incomplete or misleading diagnoses. Often it will say they died of heart failure, kidney failure, liver failure or lung failure, etc. These can be side effects of cancer treatment as well as progression of the cancer. They are neatly lumped together, reducing the general understanding of the impact of cancer.

The percentage of patients that must respond to a drug before it is approved varies from as high as 80% to as low as 20%. Thereafter, it is used routinely for all patients with the same form of cancer, though unfortunately a drug that helps one person does not necessarily mean it will help all patients with the same diagnosis. God forbid you have a medical oncologist that believes in the one drug(s) fits all patients. And the response rate for Taxol.....30%. Imagine if a patient knew beforehand that Taxol had only a 30% response rate, would that patient take the drug? This is all part of the "informed consent".

Unlike the research being performed at UCLA's Metastatic Brain Tumor Program, which is studying the effects of eliminating "whole brain" radiation from the treatment of brain metastases (debunking the effectiveness of this treatment, once and for all), no one has been doing further research on the matter of "dose intense Taxol and brain metastasis". A NCI observational study in 1995 reported experience in their clinic where recurrent systemic disease occurred in all patients for which they received dose intense Taxol therapy. Brain metastasis was the only site of the disease recurrence, presenting with headache, dizziness, unsteady gait, nausea and vomiting. Perhaps someday, an institution will do the needed research on Taxol, like UCLA is doing on "whole brain" radiation?

Next message: Linda: "Re: Please read, Ascus Cells Associated with Disease?"
Previous message: Rebecca: "vaginal pain and bump"

Women's Insurance Checklist from Auto Insurance Quote

use when must restrict search to only the women's health forum...
Enter search keywords:
	Returns per screen: Require all keywords: